BCL2 and osteonecrosis: SPION‐labelled human umbilical cord mesenchymal stem cells proved to be advantageous in osteonecrosis treatment by inhibiting apoptosis of bone cells through the Akt/Bcl‐2/Bad/Caspase‐3 signalling pathway.